Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO) as a Treatment for Postpartum Depression on July 9, 2025
SALT LAKE CITY, June 23, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to enable effective oral deli…
